Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice.

Published in:

2014

By:

• Ramratnam, Mohun;
• Sharma, Ravi K.;
• D'Auria, Stephen;
• Lee, So Jung;
• Wang, David;
• Huang, Xue Yin N.;
• Ahmad, Ferhaan

Publication type:

journal article